Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Sakamoto, Jun ^a   Barr, Rick L ^a   Kavanagh, Katherine M ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Acetyl coenzyme A carboxylase; Adenosine 5' monophosphate activated protein kinase; Carnitine palmitoyltransferase 1; Glucose oxidation; Malonyl coenzyme A

Indexed keywords

CARBOXYLYASE; CARNITINE PALMITOYLTRANSFERASE; MALONYL COENZYME A; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FATTY ACID OXIDATION; GLUCOSE OXIDATION; HEART MUSCLE METABOLISM; MALE; METABOLIC RATE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034010557     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.4.h1196     Document Type: Article

References (33)

1. Awan MM and Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 295: 61-66, 1993.
2. Chatham JC and Forder JR. Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol Heart Circ Physiol 273: H52-H58, 1997.
3. Cook GA and Gamble MS. Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA. J Biol Chem 262: 2050-2055, 1987.
4. Cook GA and Lappi MD. Carnitine palmitoyltransferase in the heart is controlled by a different mechanism than the hepatic enzyme. Mol Cell Biochem 116: 39-45, 1992.
5. Dyck JR, Barr AJ, Barr RL, Kolattukudy PE, and Lopaschuk GD. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. Am J Physiol Heart Circ Physiol 275: H2122-H2129, 1998.
6. Gamble J and Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1225: 191-199, 1994.
7. Hall JL, Stanley WC, Lopaschuk GD, Wisneski JA, Pizzurro RD, Hamilton CD, and McCormack JG. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol Heart Circ Physiol 271: H2320-H2329, 1996.
8. King MT, Reiss PD, and Cornell NW. Determination of short-chain coenzyme A compounds by reversed-phase high-performance liquid chromatography. Methods Enzymol 166: 70-79, 1988.
9. Kolodziej MP, Crilly PJ, Corstorphine CG, and Zammit VA. Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues. Biochem J 282: 415-421, 1992.
10. Kudo N, Barr AJ, Barr RL, Desai S, and Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
11. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, and Lopaschuk GD. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta 1301: 67-75, 1996.
12. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coronary Artery Dis 7: 116-123, 1996.
13. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
14. Lopaschuk GD and Gamble J. The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol 72: 1101-1109, 1994.
15. Lopaschuk GD, Lakey JR, Barr R, Wambolt R, Thomson AB, Clandinin MT, and Rajotte RV. Islet transplantation improves glucose oxidation and mechanical function in diabetic rat hearts. Can J Physiol Pharmacol 71: 896-903, 1993.
16. Lopaschuk GD and Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 65: 378-387, 1989.
17. Lopaschuk GD, Spafford MA, Davies NJ, and Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546-553, 1990.
18. Lopaschuk GD and Tsang H. Metabolism of palmitate in isolated working hearts from spontaneously diabetic "BB" Wistar rats. Circ Res 61: 853-858, 1987.
19. Lopaschuk GD, Wambolt RB, and Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144, 1993.
20. Lopaschuk GD, Witters LA, Itoi T, Barr R, and Barr A. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J Biol Chem 269: 25871-25878, 1994.
21. Makinde AO, Gamble J, and Lopaschuk GD. Upregulation of 5′-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res 80: 482-489, 1997.
22. Opie LH. Metabolism of the heart in health and disease. Am Heart J 76: 685-698, 1968.
23. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, and Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
24. Saddik M, Gamble J, Witters LA, and Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 268: 25836-25845, 1993.
25. Saddik M and Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266: 8162-8170, 1991.
26. Saddik M and Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 72: 1110-1119, 1994.
27. Saggerson D. Carnitine palmitoyltransferase in extrahepatic tissues. Biochem Soc Trans 14: 679-681, 1986.
28. Stanley WC, Lopaschuk GD, Hall JL, and McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997.
29. Stanley WC, Lopaschuk GD, and McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34: 25-33, 1997.
30. Thampy KG. Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart. J Biol Chem 264: 17631-17634, 1989.
31. Wall SR and Lopaschuk GD. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1006: 97-103, 1989.
32. Witters LA and Kemp BE. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5′-AMP-activated protein kinase. J Biol Chem 267: 2864-2867, 1992.
33. Woeltje KF, Esser V, Weis BC, Cox WF, Schroeder JG, Liao ST, Foster DW, and McGarry JD. Inter-tissue and interspecies characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system. J Biol Chem 265: 10714-10719, 1990.